Shouldn't the shareholders be given a reason why they can't get 100 people dosed in a 6 month period in the entire United States? If you are going to give a shareholder update and kill short term momentum how can you not give an explanation for it.
yeah and thats just for full enrollment, full results will be some where in the middle of 2022! to me a total waste of time and money. If they focused on the CLI trial and got the interim results in May out on time they could be going for conditional approval this year! The market did not seem to like the update either
News 
Market Data 
Discover 
